Table 2.
Subgroup Analysis of Per-Pathogen Microbiological Treatment Success
| No. of Patients Successfully Treated/Total No. (%) | OR (95% CI) | ||
|---|---|---|---|
| Carbapenems | β-Lactams | ||
| E. coli | 814/929 (87.62) | 866/968 (89.37) | 0.84 (0.63–1.12) |
| K. pneumoniae | 128/147 (87.07) | 112/129 (86.82) | 1.05 (0.52–2.15) |
| P. aeruginosa | 105/114 (92.11) | 87/97 (89.69) | 1.24 (0.51–3.02) |
| Enterobacter spp. | 127/134 (94.78) | 96/103 (93.20) | 1.69 (0.59–4.85) |
| Enterococcus spp. | 60/72 (83.33) | 55/61 (90.16) | 0.65 (0.23–1.82) |
Abbreviations: CI, confidence interval; OR, odds ratio.